- Iida T, Kijima H, Urata Y, Goto S, Ihara Y, Oka M, Kohno S, Scanlon KJ, Kondo T. Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins. Cancer Gene Ther. 2001 Oct; 8(10): 803-14.
- Iida T, Mori E, Mori K, Goto S, Urata Y, Oka M, Kohno S, Kondo T. Co-expression of gamma-glutamylcysteine synthetase sub-units in response to cisplatin and doxorubicin in human cancer cells. Int J Cancer. 1999 Jul 30; 82(3): 405-11.
- Goto S, Iida T, Cho S, Oka M, Kohno S, Kondo T. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free Radic Res. 1999 Dec; 31(6): 549-58.
- Kijima H, Tsuchida T, Kondo H, Iida T, Oshika Y, Nakamura M, Scanlon KJ, Kondo T, Tamaoki N. Hammerhead ribozymes against gamma-glutamylcysteine synthetase mRNA down-regulate intracellular glutathione concentration of mouse islet cells. Biochem Biophys Res Commun. 1998 Jun 29; 247(3): 697-703.
- Iwanaga M, Mori K, Iida T, Urata Y, Matsuo T, Yasunaga A, Shibata S, Kondo T. Nuclear factor kappa B dependent induction of gamma glutamylcysteine synthetase by ionizing radiation in T98G human glioblastoma cells. Free Radic Biol Med. 1998 May; 24(7-8): 1256-68.
|
|
